Literature DB >> 8164647

Induction of the rat prodynorphin gene through Gs-coupled receptors may involve phosphorylation-dependent derepression and activation.

J Collins-Hicok1, L Lin, C Spiro, P J Laybourn, R Tschumper, B Rapacz, C T McMurray.   

Abstract

Prodynorphin transcription is activated via Gs-coupled receptors through a cyclic AMP (cAMP)-dependent pathway. Four cAMP response elements (CREs) are present within the rat prodynorphin (RD) control region, and all four CREs appear to function in RD regulation. Three CREs located upstream between -1860 and -1504 are critical for receptor-responsive activity, but their function is distance dependent unless they act together with a fourth CRE found in exon 1. Regulation of RD also appears to involve multiple CRE-binding proteins. Both CRE-binding protein (CREB) and activator protein 1 (AP-1) can regulate RD, but their effects are in opposite directions; CREB represses and AP-1 activates RD. CREB-induced repression and AP-1 activation require distinct elements within the control region, but their binding and functions overlap at CRE-3. While CREB repression is dependent on CRE-3, AP-1 activation (and cAMP induction) of RD requires additional CREs (CRE-1, -2, and -4). CREB repression blocks AP-1 activation in unstimulated cells. However, phosphorylation relieves CREB-induced repression and enhances AP-1 activation. Gs-coupled receptor activation of RD may require phosphorylation-dependent derepression and activation steps.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8164647      PMCID: PMC358652          DOI: 10.1128/mcb.14.5.2837-2848.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

1.  CAT vectors for analysis of eukaryotic promoters and enhancers.

Authors:  E Prost; D D Moore
Journal:  Gene       Date:  1986       Impact factor: 3.688

2.  Regulated expression of the prodynorphin gene in the R2C Leydig tumor cell line.

Authors:  C T McMurray; L Devi; L Calavetta; J O Douglass
Journal:  Endocrinology       Date:  1989-01       Impact factor: 4.736

3.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

4.  Structure and chromosomal localization of the functional intronless human JUN protooncogene.

Authors:  K Hattori; P Angel; M M Le Beau; M Karin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization.

Authors:  M J Iadarola; J Douglass; O Civelli; J R Naranjo
Journal:  Brain Res       Date:  1988-07-12       Impact factor: 3.252

6.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

7.  Single or repeated electroconvulsive shocks alter the levels of prodynorphin and proenkephalin mRNAs in rat brain.

Authors:  C W Xie; P H Lee; K Takeuchi; V Owyang; S J Li; J Douglass; J S Hong
Journal:  Brain Res Mol Brain Res       Date:  1989-07

8.  Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element.

Authors:  P Sassone-Corsi; J Visvader; L Ferland; P L Mellon; I M Verma
Journal:  Genes Dev       Date:  1988-12       Impact factor: 11.361

9.  In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia.

Authors:  M A Ruda; M J Iadarola; L V Cohen; W S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

10.  Proteins bound at adjacent DNA elements act synergistically to regulate human proenkephalin cAMP inducible transcription.

Authors:  M Comb; N Mermod; S E Hyman; J Pearlberg; M E Ross; H M Goodman
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

View more
  9 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  Protein kinase A-dependent derepression of the human prodynorphin gene via differential binding to an intragenic silencer element.

Authors:  A M Carrión; B Mellström; J R Naranjo
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

3.  [Leu5]enkephalin-encoding sequences are targets for a specific DNA-binding factor.

Authors:  G Bakalkin; M Telkov; T Yakovleva; L Terenius
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

4.  cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum.

Authors:  M Andersson; C Konradi; M A Cenci
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

5.  CREB involvement in the regulation of striatal prodynorphin by nicotine.

Authors:  Michael J McCarthy; Anne-Marie Duchemin; Norton H Neff; Maria Hadjiconstantinou
Journal:  Psychopharmacology (Berl)       Date:  2011-11-17       Impact factor: 4.530

6.  Chromatin alterations in response to forced swimming underlie increased prodynorphin transcription.

Authors:  B Reed; N Fang; B Mayer-Blackwell; S Chen; V Yuferov; Y Zhou; M J Kreek
Journal:  Neuroscience       Date:  2012-06-12       Impact factor: 3.590

7.  Protein kinase C-regulated cAMP response element-binding protein phosphorylation in cultured rat striatal neurons.

Authors:  Li-Min Mao; Qingsong Tang; John Q Wang
Journal:  Brain Res Bull       Date:  2007-01-31       Impact factor: 4.077

8.  Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum.

Authors:  R L Cole; C Konradi; J Douglass; S E Hyman
Journal:  Neuron       Date:  1995-04       Impact factor: 17.173

9.  DREAM is reduced in synovial fibroblasts of patients with chronic arthritic pain: is it a suitable target for peripheral pain management?

Authors:  Natasa Reisch; Andrea Engler; André Aeschlimann; Beat R Simmen; Beat A Michel; Renate E Gay; Steffen Gay; Haiko Sprott
Journal:  Arthritis Res Ther       Date:  2008-05-28       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.